24/7 Patient Assistance: 760-405-8205

Gregory P. Kalemkerian, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pleural Mesothelioma Testicular Mesothelioma

specialties & services

  • Bio & Insurance Information

    A professor of medical oncology at the University of Michigan Health System, Dr. Kalemkerian has studied at the Northwestern University Medical School in Chicago, completing his studies in 1985. He then went on to complete his residency at the Northwestern Memorial Hospital. His fellowship was completed at the Johns Hopkins Hospital in Baltimore. With two board certifications in internal medicine and medical oncology, Dr. Gregory Kalemkerian is a specialist in mesothelioma. His main focus in this area have been clinical trials of new and improved treatment methods for this type of cancer.


  • Education & Training

    dept_icon

    Northwestern University Medical School, Chicago, IL - 1985

    Medical School

    dept_icon

    Northwestern Memorial Hospital, Chicago, IL - 1988

    Residency

    dept_icon

    Johns Hopkins Hospital, Baltimore, MD - 1993

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    University of Michigan Comprehensive Cancer Center

    Languages: English/Spanish

    (800) 865-1125

    1500 E Medical Center Dr

    Ann Arbor, Michigan 48109

    Read More

    VA Ann Arbor Healthcare System

    Languages: English/Spanish

    (734) 769-7100

    2215 Fuller Rd

    Ann Arbor, Miami 48105

    Read More
  • Publications & Memberships

    Dr. Gregory P. Kalemkerian has contributed to 4 publications.

    A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer.

    Ramnath N1, Daignault-Newton S, Dy GK, Muindi JR, Adjei A, Elingrod VL, Kalemkerian GP, Cease KB, Stella PJ, Brenner DE, Troeschel S, Johnson CS, Trump DL.

    See more >>

    Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma.

    Hassan KA1, Wang L, Korkaya H, Chen G, Maillard I, Beer DG, Kalemkerian GP, Wicha MS.

    See more >>

    Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.

    Ferketich AK1, Niland JC, Mamet R, Zornosa C, D'Amico TA, Ettinger DS, Kalemkerian GP, Pisters KM, Reid ME, Otterson GA.

    See more >>

    The Application of Molecular Diagnostic Studies Interrogating EGFR and KRAS Mutations to Stained Cytologic Smears of Lung Carcinoma.

    Betz BL1, Roh MH, Weigelin HC, Placido JB, Schmidt LA, Farmen S, Arenberg DA, Kalemkerian GP, Knoepp SM.

    See more >>

    Memberships

    American College of Physicians

    American Society of Clinical Oncology

Verified Patient Reviews

Rate This Doctor

March 29, 2016

by Barb L.

Wait Time

Staff

Helpfulness

Knowledge

“Dr. Kalemkerian cares indeed about his patients. He explains the diagnosis and treatment in a language that anyone can understand it. You can also get in touch with him via e-mail. I have emailed him a few times and he always replied after a couple of hours.”

October 04, 2013

by Rachel O.

Wait Time

Staff

Helpfulness

Knowledge

“Dr. Kalemkerian is a great doctor with a big heart! I thank God for doctors like him.”

October 30, 2012

by Carl W.

Wait Time

Staff

Helpfulness

Knowledge

“My 92-year-old father has been diagnosed with cancer a year ago and Dr. Kalemkerian was our greatest help. Most of the doctors rejected my father because he was too old, but not Dr. Kal! He looked overall at my dad’s general health and took action. Thanks to Dr. Kal my dad is still alive and doing well. He makes time and answers all of our questions and concerns. He even calls his patients after hours. Simply the best!”